Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01094223 · ClinicalTrials.gov registry record · NA
Mindfulness Based Relapse Prevention for Stimulant Users
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT01094223 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 62 participants.
The verdict
NCT01094223, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The broad, long-term objective of the current research is to improve treatment for stimulant use disorders by augmenting traditional relapse prevention therapy with innovative meditation-based strategies to promote affect regulation skills. Based on Mindfulness-Based Cognitive Therapy for depression (Segal, Teasdale, \& Williams, 2002), Marlatt and colleagues recently developed a manualized intervention for the treatment of substance using populations: Mindfulness Based Relapse Prevention (MBRP). The specific aims of this research are 1) To conduct a pilot randomized clinical trial to assess the feasibility of recruiting and retaining individuals for a large scale study and to determine the effect size of MBRP relative to a health education (ED) control group in stimulant users receiving contingency management (CM).
Interventions
- BEHAVIORAL Health Education
- BEHAVIORAL Mindfulness Based Relapse Prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01094223
The ClinicalTrials.gov registry entry for NCT01094223 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Health Education is the first listed.
NCT01094223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01094223 about?
NCT01094223 is a clinical study titled "Mindfulness Based Relapse Prevention for Stimulant Users". The broad, long-term objective of the current research is to improve treatment for stimulant use disorders by augmenting traditional relapse prevention therapy with innovative meditation-based strategies to promote affect regulation skills. Based on Mindfulness-Based Cognitive Therapy for depression...
What is the current status of trial NCT01094223?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2010-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01094223?
The interventions under investigation include: Health Education (BEHAVIORAL), Mindfulness Based Relapse Prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01094223?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.